cilostazol has been researched along with Cardiac Remodeling, Ventricular in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To observe the dynamic changes of plasma matrix metalloproteinases (MMPs) and investigate the effect of early or delayed percutaneous coronary intervention (PCI) in the presence or absence cilostazol on left ventricle (LV) remodeling in patients with non-ST elevation myocardial infarction (NSTEMI)." | 9.14 | [Effect of percutaneous coronary intervention timing and cilostazol use on left ventricular remodeling in patients with non-ST elevation myocardial infarction]. ( Chen, LL; Feng, GB; Han, YL; Sun, F; Wang, SL; Yan, CH; Zhao, X, 2010) |
| "Cilostazol, a phosphodiesterase inhibitor, is an antiplatelet agent with positive chronotropic effect, the impact of which on left ventricular (LV) volume and function in acute myocardial infarction (AMI) was evaluated in the present study." | 7.74 | Impact of chronotropic effect of cilostazol after acute myocardial infarction: insights from change in left ventricular volume and function. ( Choi, S; Choi, SH; Choi, YJ; Han, KR; Hong, KS; Jung, JH; Lee, N; Lee, SH; Oh, DJ; Park, DG; Rhim, CY, 2007) |
| "To observe the dynamic changes of plasma matrix metalloproteinases (MMPs) and investigate the effect of early or delayed percutaneous coronary intervention (PCI) in the presence or absence cilostazol on left ventricle (LV) remodeling in patients with non-ST elevation myocardial infarction (NSTEMI)." | 5.14 | [Effect of percutaneous coronary intervention timing and cilostazol use on left ventricular remodeling in patients with non-ST elevation myocardial infarction]. ( Chen, LL; Feng, GB; Han, YL; Sun, F; Wang, SL; Yan, CH; Zhao, X, 2010) |
| "Cilostazol, a phosphodiesterase inhibitor, is an antiplatelet agent with positive chronotropic effect, the impact of which on left ventricular (LV) volume and function in acute myocardial infarction (AMI) was evaluated in the present study." | 3.74 | Impact of chronotropic effect of cilostazol after acute myocardial infarction: insights from change in left ventricular volume and function. ( Choi, S; Choi, SH; Choi, YJ; Han, KR; Hong, KS; Jung, JH; Lee, N; Lee, SH; Oh, DJ; Park, DG; Rhim, CY, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, SL | 1 |
| Sun, F | 1 |
| Zhao, X | 1 |
| Chen, LL | 1 |
| Feng, GB | 1 |
| Yan, CH | 1 |
| Han, YL | 1 |
| Lee, SH | 1 |
| Choi, SH | 1 |
| Choi, S | 1 |
| Jung, JH | 1 |
| Lee, N | 1 |
| Choi, YJ | 1 |
| Park, DG | 1 |
| Hong, KS | 1 |
| Han, KR | 1 |
| Oh, DJ | 1 |
| Rhim, CY | 1 |
| Sanganalmath, SK | 1 |
| Barta, J | 1 |
| Takeda, N | 1 |
| Kumamoto, H | 1 |
| Dhalla, NS | 1 |
1 trial available for cilostazol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
[Effect of percutaneous coronary intervention timing and cilostazol use on left ventricular remodeling in patients with non-ST elevation myocardial infarction].
Topics: Aged; Angioplasty, Balloon, Coronary; Cilostazol; Electrocardiography; Female; Humans; Male; Matrix | 2010 |
2 other studies available for cilostazol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Impact of chronotropic effect of cilostazol after acute myocardial infarction: insights from change in left ventricular volume and function.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cilostazol; Drug | 2007 |
Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Cilostazol; Disease Models, Animal; Echocardiography; Electrocardiogr | 2008 |